...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Liquidity
4
Jan 21, 2016 06:56PM
5
Jan 21, 2016 07:20PM
1
Jan 22, 2016 09:36AM
1
Jan 22, 2016 05:05PM

ToInv..."KBC your reply got me thinking about another of Don's Comments from the AGM (based on masila's notes).

"Regarding the IPO on Nasdaq, I’ve said in the past I would never do another TSX listing – well, I’m looking at a TSX listing. One reason is that some resource companies that are not faring too well. I’m thinking that we might do a reverse takeover of one of these companies who might already have a Nasdaq listing. We’re still working on these angles to determine how viable that would be. My lawyer hasn’t even heard about this."

That's just their particular lawyer I think. Reverse takeovers are common.

BNN: Why companies choose the reverse takeover route

Fri, Jun 26, 2015 - 10:10 AM
So far this year, 11% of new listings filed on the TSX Venture have debuted through a reverse takeover. RTOs have been viewed as a cost-effective option for early-stage companies. BNN analyzes the advantages and challenges of RTOs from a legal point-of-view with Krisztián Tóth, Partner, Fasken Martineau. Why do companies take the RTO route?"

http://www.bnn.ca/Video/player.aspx?vid=644583

Hard to know what will happen or when regarding an IPO or public listing, Canada or US. I'm sure Don will figure out what makes the most sense.

4
Jan 22, 2016 06:36PM
4
Jan 24, 2016 11:53AM
5
Jan 24, 2016 12:49PM
2
Jan 24, 2016 07:00PM
Share
New Message
Please login to post a reply